[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556708":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":11,"centralContacts":26,"locations":32,"responsibleParty":49,"collaborators":51,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":65,"sex":66,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":11,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":11,"overallStatus":35,"whyStopped":11,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","OTHER",[8,12,17],{"label":9,"type":10,"description":11,"interventionNames":11},"Observational","NO_INTERVENTION",null,{"label":13,"type":14,"description":11,"interventionNames":15},"self-questionnaire SQ-R&IC","ACTIVE_COMPARATOR",[16],"Diagnostic Test: rapid HIV and HCV serological tests",{"label":18,"type":14,"description":11,"interventionNames":19},"rapid HIV and HCV serological tests",[16],[21],{"type":22,"name":18,"description":23,"armGroupLabels":24,"otherNames":25},"DIAGNOSTIC_TEST","In the standard of care branch (SOC), the health personnel will ask people a series of questions to identify the HIV risk exposition, and also they will be provided pop-up computer alerts of HIV indicator conditions in the electronic medical record, moreover HIV and HCV serological tests will be carried out in the reference laboratory, while in the intervention branch in addition to the SOC, a SQ-R\\&IC of HIV and HCV will be made available to the HC population, through a quick response (QR) code, as well as HIV and HCV RT.",[18,13],[13],[27],{"name":28,"role":29,"phone":30,"phoneExt":11,"email":31},"Maria J. Vivancos-Gallego, MD, PhD","CONTACT","+34913368672","mariajesus.vivancos@salud.madrid.org",[33],{"facility":34,"status":35,"city":36,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Maria J. Vivancos-Gallego","RECRUITING","Madrid","28034","Spain","ES",{"type":41,"coordinates":42},"Point",[43,44],-3.70256,40.4165,{"lat":44,"lon":43},[47],{"name":48,"role":29,"phone":30,"phoneExt":11,"email":31},"Maria J. Vivancos Gallego, MD, PhD",{"type":50,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[52,55],{"name":53,"class":54},"Consorcio Centro de Investigación Biomédica en Red (CIBER)","OTHER_GOV",{"name":56,"class":6},"European Union","100556708","tools-to-identify-people-at-risk-or-already-infected-with-hiv-and-hcv-100556708",false,"NCT06528626","Tools to Identify People At Risk or Already Infected with HIV and HCV","Wedge-Shaped Clusterded Randomizad Trial to Evaluate Two Tools to Identify People At Risk or Already Infected with HIV and HCV","ATENEA","Inclusion Criteria:\n\n\\- 14-65 years in the health area or who are captured for inclusion by health personnel. They give their consent to participate.\n\nExclusion Criteria:\n\n* Having already been included in the study, not signing the consent.",true,"ALL","14 Years","65 Years",{"count":70,"type":71},240000,"ESTIMATED","INTERVENTIONAL",[74],"NA","Wedge-Shaped Clusterded Randomizad Trial to Evaluate Two Tools to identify People at Risk or already Infected with HIV and HCV",[77,78,79],"HIV\u002FAIDS","STD","HCV","2025-02-27",{"date":82,"type":83},"2025-03-03","ACTUAL",{"date":85,"type":83},"2023-07-01",{"date":87,"type":71},"2025-12-01",{"name":5,"class":6},1]